- Medical School - University of New Delhi Maulana Azad Medical College, India (2001-2007)
- Residency - Lok Nayak Hospital, India (2008-2008)
- Residency - UT Southwestern Medical Center (2008-2012), Psychiatry
Manish Jha, M.D.
- O'Donnell Clinical Neuroscience Scholar
- Psychiatry
New Patient Appointment Accepting Virtual Visits or 214-645-8500
Education & Training
Professional Associations & Affiliations
- Clinical Psychology graduate program (2016)
Books & Publications
-
Publications
-
Clinical and sociodemographic features of the Texas resilience against depression (T-RAD) study: Findings from the initial cohort.
Trivedi MH, Jha MK, Elmore JS, Carmody T, Chin Fatt C, Sethuram S, Wang T, Mayes TL, Foster JA, Minhajuddin A, Journal of affective disorders 2024 Nov 364 146-156 -
Substance use patterns and mental health comorbidities in youth with a history of depression or suicidality: Findings from TX-YDSRN.
Clark SL, Dodd CG, Mitchell TB, Ingram SJ, Armstrong GM, Jha MK, Soares JC, Smith M, Minhajuddin A, Slater H, Wakefield SM, Trivedi MH, Journal of affective disorders 2024 Aug -
Problematic substance use in depressed adolescents: Prevalence and clinical correlates.
Marino EN, Jha MK, Minhajuddin A, Ayvaci ER, Levinson S, Pipes R, Emslie GJ, Trivedi MH, Addictive behaviors reports 2024 Jun 19 100539 -
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
Jha MK, Wilkinson ST, Krishnan K, Collins KA, Sanacora G, Murrough J, Goes F, Altinay M, Aloysi A, Asghar-Ali A, Barnett B, Chang L, Costi S, Malone D, Nikayin S, Nissen SE, Ostroff R, Reti I, Wolski K, Wang D, Hu B, Mathew SJ, Anand A, JAMA network open 2024 Jun 7 6 e2417786 -
Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial.
Li MJ, Chau B, Belin T, Carmody T, Jha MK, Marino EN, Trivedi M, Shoptaw SJ, Addiction (Abingdon, England) 2024 Jun -
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
Papakostas GI, Trivedi MH, Shelton RC, Iosifescu DV, Thase ME, Jha MK, Mathew SJ, DeBattista C, Dokucu ME, Brawman-Mintzer O, Currier GW, McCall WV, Modirrousta M, Macaluso M, Bystritsky A, Rodriguez FV, Nelson EB, Yeung AS, Feeney A, MacGregor LC, Carmody T, Fava M, Molecular psychiatry 2024 Mar -
Treatment of Adolescent Depression: Comparison of Psychiatric and Pediatric Settings at an Academic Medical Center Using the VitalSign6 Application.
Ayvaci ER, Minhajuddin A, Elmore JS, Yagnik K, Jha MK, Emslie GJ, Mayes TL, Trivedi MH, Journal of child and adolescent psychopharmacology 2024 Jan -
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.
Vreijling SR, Chin Fatt CR, Williams LM, Schatzberg AF, Usherwood T, Nemeroff CB, Rush AJ, Uher R, Aitchison KJ, Köhler-Forsberg O, Rietschel M, Trivedi MH, Jha MK, Penninx BWJH, Beekman ATF, Jansen R, Lamers F, The British journal of psychiatry : the journal of mental science 2023 Dec 1-9 -
Data-driven subgrouping of youths with depression reveals that resilience is associated with higher physical functioning despite high symptom burden in the Texas Youth Depression and Suicide Research Network (TX-YDSRN).
Minhajuddin A, Jha MK, Slater H, Mayes TL, Storch EA, Shotwell J, Soutullo C, Wakefield SM, Trivedi MH, Journal of affective disorders 2023 Dec -
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?
Mathew SJ, Jha MK, Anand A, JAMA psychiatry 2023 Oct -
Predicting suicidal events: A comparison of the Concise Health Risk Tracking Self-Report (CHRT-SR) and the Columbia Suicide Severity Rating Scale (C-SSRS).
Mayes TL, Carmody T, Rush AJ, Nandy K, Emslie GJ, Kennard BD, Forbes K, Jha MK, Hughes JL, Heerschap JK, Trivedi MH, Psychiatry research 2023 Aug 326 115306 -
The clinical, economic, and patient-centric burden of insomnia symptom severity in adults with major depressive disorder in the United States.
Joshi K, Cambron-Mellott MJ, Costantino H, Pfau A, Jha MK, Brain and behavior 2023 Jul e3143 -
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS, Focus (American Psychiatric Publishing) 2023 Jul 21 3 296-305 -
Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial.
Giles MA, Cooper CM, Jha MK, Chin Fatt CR, Pizzagalli DA, Mayes TL, Webb CA, Greer TL, Etkin A, Trombello JM, Chase HW, Phillips ML, McInnis MG, Carmody T, Adams P, Parsey RV, McGrath PJ, Weissman M, Kurian BT, Fava M, Trivedi MH, Behavioral sciences (Basel, Switzerland) 2023 Jul 13 8 -
The Individual and Societal Burden of Treatment-Resistant Depression: An Overview.
Baig-Ward KM, Jha MK, Trivedi MH, The Psychiatric clinics of North America 2023 Jun 46 2 211-226 -
Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.
Vas C, Jain A, Trivedi M, Jha MK, Mathew SJ, The Psychiatric clinics of North America 2023 Jun 46 2 261-275 -
Role of Psychedelics in Treatment-Resistant Depression.
Kamal S, Jha MK, Radhakrishnan R, The Psychiatric clinics of North America 2023 Jun 46 2 291-305 -
Approach to Diagnosis and Management of Treatment-Resistant Depression.
Rikhani K, Vas C, Jha MK, The Psychiatric clinics of North America 2023 Jun 46 2 247-259 -
Treatment-Resistant Depression (TRD): Management Approaches in a Rapidly Evolving Therapeutic Landscape.
Jha MK, Trivedi MH, The Psychiatric clinics of North America 2023 Jun 46 2 xiii-xiv -
Psychometric properties of Concise Associated Symptom Tracking (CAST) scale in youths and young adults: Findings from the Texas youth depression and suicide research network (TX-YDSRN).
Jha MK, Minhajuddin A, Slater H, Mayes TL, Blader J, Brown R, Garza C, Kennard BD, Riddle D, Storch EA, Shotwell J, Soutullo CA, Wakefield SM, Trivedi MH, Journal of psychiatric research 2023 May 161 179-187 -
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, Aloysi AS, Asghar-Ali AA, Barnett BS, Chang LC, Collins KA, Costi S, Iqbal S, Jha MK, Krishnan K, Malone DA, Nikayin S, Nissen SE, Ostroff RB, Reti IM, Wilkinson ST, Wolski K, Hu B, The New England journal of medicine 2023 May -
Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study.
Chin Fatt CR, Asbury S, Jha MK, Minhajuddin A, Sethuram S, Mayes T, Kennedy SH, Foster JA, Trivedi MH, Translational psychiatry 2023 Apr 13 1 139 -
Characterizing inflammatory profiles of suicidal behavior in adolescents: Rationale and design.
Chin Fatt C, Ayvaci ER, Jha MK, Emslie G, Gibson S, Minhajuddin AT, Mayes TL, Farrar JD, Trivedi MH, Journal of affective disorders 2023 Mar 325 55-61 -
Early reduction in irritability is associated with improved outcomes among youth with depression: Findings from the AMOD study.
Mohamed AK, Croarkin PE, Jha MK, Vande Voort JL, Journal of affective disorders 2023 Mar 324 77-81 -
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
Jha MK, Mathew SJ, The American journal of psychiatry 2023 Mar 180 3 190-199 -
Data driven clusters derived from resting state functional connectivity: Findings from the EMBARC study.
Chin Fatt CR, Minhajuddin A, Jha MK, Mayes T, Rush AJ, Trivedi MH, Journal of psychiatric research 2023 Feb 158 150-156 -
The real-world burden of adults with major depressive disorder with moderate or severe insomnia symptoms in the United States.
Joshi K, Cambron-Mellott MJ, Costantino H, Pfau A, Jha MK, Journal of affective disorders 2023 Feb 323 698-706 -
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics.
Carreon RL, Rivas-Grajales AM, Murphy N, Mathew SJ, Jha MK, Advances in neurobiology 2023 30 287-297 -
A randomized pilot study of the prophylactic effect of ketamine on laboratory-induced stress in healthy adults.
Costi S, Evers A, Jha MK, Klein M, Overbey JR, Goosens KA, Burgess J, Alvarez K, Feder A, Charney DS, Murrough JW, Neurobiology of stress 2023 Jan 22 100505 -
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
Jha MK, Williamson DJ, Magharehabed G, Turkoz I, Daly EJ, Trivedi MH, Journal of affective disorders 2023 Jan 321 153-160 -
Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis.
Hock RS, Feeney A, Iovieno N, Murrough JW, Mathew SJ, Iosifescu DV, Fava M, Jha MK, Papakostas GI, The Journal of clinical psychiatry 2022 Dec 84 1 -
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study.
Feeney A, Hoeppner BB, Freeman MP, Flynn M, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, DeBattista C, Ionescu DF, Cusin C, Papakostas GI, Jha MK, Fava M, The Journal of clinical psychiatry 2022 Nov 84 1 -
Immune characterization of suicidal behavior in female adolescents.
Chin Fatt CR, Farrar JD, Jha MK, Minhajuddin A, Mayes T, Foster JA, Trivedi MH, Brain, behavior, & immunity - health 2022 Nov 25 100499 -
Accelerated brain aging in individuals with diabetes: Association with poor glycemic control and increased all-cause mortality.
Jha MK, Chin Fatt CR, Minhajuddin A, Mayes TL, Berry JD, Trivedi MH, Psychoneuroendocrinology 2022 Sep 145 105921 -
Accelerated Brain Aging in Adults with Major Depressive Disorder Predicts Poorer Outcome with Sertraline: Findings from the EMBARC Study.
Jha MK, Fatt CC, Minhajuddin A, Mayes T, Trivedi MH, Biological psychiatry. Cognitive neuroscience and neuroimaging 2022 Sep -
Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trial.
Trombello JM, Cooper CM, Fatt CC, Grannemann BD, Carmody TJ, Jha MK, Mayes TL, Greer TL, Yezhuvath U, Aslan S, Pizzagalli DA, Weissman MM, Webb CA, Dillon DG, McGrath PJ, Fava M, Parsey RV, McInnis MG, Etkin A, Trivedi MH, Journal of psychiatric research 2022 Mar 149 243-251 -
Antidepressant effect of prolonged twice-weekly intranasal esketamine treatments after nonresponse to electroconvulsive therapy in a patient with treatment-resistant depression.
Evers A, Klein M, Aloysi A, Murrough J, Jha MK, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2022 Feb 34 1 61-64 -
Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory.
Mason BL, Minhajuddin A, Czysz AH, Jha MK, Gadad BS, Mayes TL, Trivedi MH, Translational psychiatry 2022 01 12 1 16 -
COVID 19-related burnout among healthcare workers in India and ECG based predictive machine learning model: Insights from the BRUCEE- Li study.
Gupta MD, Jha MK, Bansal A, Yadav R, Ramakrishanan S, Girish MP, Sarkar PG, Qamar A, Kumar S, Kumar S, Jain A, Saijpaul R, Gupta V, Kansal D, Garg S, Arora S, Biswas PS, Yusuf J, Malhotra RK, Batra V, Kathuria S, Mehta V, SafalShetty MK, Mukhopadhyay S, Tyagi S, Gupta A, Indian heart journal 2021 Oct -
Dysfunction of default mode network is associated with active suicidal ideation in youths and young adults with depression: Findings from the T-RAD study.
Chin Fatt CR, Jha MK, Minhajuddin A, Mayes T, Ballard ED, Trivedi MH, Journal of psychiatric research 2021 Oct 142 258-262 -
Smoking status links habenular volume to glycated hemoglobin: Findings from the Human Connectome Project-Young Adult.
Jha MK, Kim JW, Kenny PJ, Chin Fatt C, Minhajuddin A, Salas R, Ely BA, Klein M, Abdallah CG, Xu J, Trivedi MH, Psychoneuroendocrinology 2021 Sep 131 105321 -
Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial.
Nguyen KP, Chin Fatt C, Treacher A, Mellema C, Cooper C, Jha MK, Kurian B, Fava M, McGrath PJ, Weissman M, Phillips ML, Trivedi MH, Montillo AA, Biological psychiatry 2021 Sep -
Irritability as an independent predictor of concurrent and future suicidal ideation in adults with stimulant use disorder: Findings from the STRIDE study.
Jha MK, Minhajuddin A, Chin Fatt C, Shoptaw S, Kircanski K, Stringaris A, Leibenluft E, Trivedi M, Journal of affective disorders 2021 09 292 108-113 -
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.
Norbury A, Rutter SB, Collins AB, Costi S, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Glasgow AM, Brallier J, Shin LM, Charney DS, Murrough JW, Feder A, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2021 Jul -
Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset.
Iovieno N, Papakostas GI, Feeney A, Fava M, Mathew SJ, Iosifescu DI, Murrough JW, Macaluso M, Hock RS, Jha MK, The Journal of clinical psychiatry 2021 Jun 82 4 -
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, Iqbal T, Chadha N, Pizzagalli DA, Whitton A, Bevilacqua L, Jha MK, Ursu S, Swann AC, Collins KA, Salas R, Bagiella E, Parides MK, Stern ER, Iosifescu DV, Han MH, Mathew SJ, Murrough JW, The American journal of psychiatry 2021 05 178 5 437-446 -
Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life: Findings From the EMBARC and STRIDE Studies and the VitalSign6 Project.
Jha MK, Schatzberg A, Minhajuddin A, Chin Fatt C, Mayes TL, Trivedi MH, The Journal of clinical psychiatry 2021 Apr 82 3 -
Preliminary Evidence for Sociotropy and Autonomy in Relation to Antidepressant Treatment Outcome.
Cardinale R, Menkes MW, Andrews CM, Webb CA, Jha MK, Trombello JM, Trivedi MH, McInnis MG, Deldin PJ, The Psychiatric quarterly 2021 Feb -
Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study.
Jha MK, Fava M, Minhajuddin A, Chin Fatt C, Mischoulon D, Cusin C, Trivedi MH, Depression and anxiety 2021 01 38 1 57-66 -
Design and rationale of an intelligent algorithm to detect BuRnoUt in HeaLthcare workers in COVID era using ECG and artificiaL intelligence: The BRUCEE-LI study.
Gupta MD, Bansal A, Sarkar PG, Girish MP, Jha M, Yusuf J, Kumar S, Kumar S, Jain A, Kathuria S, Saijpaul R, Mishra A, Malhotra V, Yadav R, Ramakrishanan S, Malhotra RK, Batra V, Shetty MK, Sharma N, Mukhopadhyay S, Garg S, Gupta A, Indian heart journal 2021 Jan-Feb 73 1 109-113 -
Quality of life after response to acute-phase cognitive therapy for recurrent depression.
Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB, Journal of affective disorders 2021 01 278 218-225 -
Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.
Chin Fatt CR, Cooper C, Jha MK, Aslan S, Grannemann B, Kurian B, Greer TL, Fava M, Weissman M, McGrath PJ, Parsey RV, Etkin A, Phillips ML, Trivedi MH, Biological psychiatry. Cognitive neuroscience and neuroimaging 2021 01 6 1 20-28 -
Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study.
Shelton RC, Fava M, Freeman MP, Thase ME, Papakostas GI, Jha MK, Trivedi MH, Dirks B, Liu K, Stankovic S, Journal of affective disorders 2020 12 277 478-485 -
Association between irritability and suicidal ideation in three clinical trials of adults with major depressive disorder.
Jha MK, Minhajuddin A, Chin Fatt C, Kircanski K, Stringaris A, Leibenluft E, Trivedi MH, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2020 Jul -
Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Jha MK, Minhajuddin A, South C, Rush AJ, Trivedi MH, The American journal of psychiatry 2019 May 176 5 358-366 -
Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review.
Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW, Journal of the American College of Cardiology 2019 04 73 14 1827-1845 -
Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial.
Gadad BS, Raj P, Jha MK, Carmody T, Dozmorov I, Mayes TL, Wakeland EK, Trivedi MH, Molecular neuropsychiatry 2018 Jun 4 1 7-19 -
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
Gadad BS, Jha MK, Grannemann BD, Mayes TL, Trivedi MH Journal of psychiatric research 2017 May 94 1-6 -
Is C-reactive protein ready for prime time in the selection of antidepressant medications?
Miller AH, Trivedi MH, Jha MK Psychoneuroendocrinology 2017 Apr -
A pilot program for implementing mental health screening, assessment, and navigation in a community-based cancer center.
Howe-Martin L, Jester B, Walker R, de la Garza N, Jha MK, Tovian C, Levinson S, Argenbright KE, Trivedi MH Psycho-oncology 2017 Mar -
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder.
Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH Neuropsychiatric disease and treatment 2017 13 803-813 -
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
Jha MK, Minhajuddin A, Gadad BS, Greer T, Grannemann B, Soyombo A, Mayes TL, Rush AJ, Trivedi MH Psychoneuroendocrinology 2017 Jan 78 105-113 -
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.
Jha MK, Minhajuddin A, Greer TL, Carmody T, Rush AJ, Trivedi MH The American journal of psychiatry 2016 Aug appiajp201616020176 -
Affect Following First Exercise Session as a Predictor of Treatment Response in Depression.
Suterwala AM, Rethorst CD, Carmody TJ, Greer TL, Grannemann BD, Jha M, Trivedi MH The Journal of clinical psychiatry 2016 Aug 77 8 1036-42 -
Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial.
Jha MK, Greer TL, Grannemann BD, Carmody T, Rush AJ, Trivedi MH Journal of affective disorders 2016 Jul 206 17-22 -
IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.
Greer TL, Trombello JM, Rethorst CD, Carmody TJ, Jha MK, Liao A, Grannemann BD, Chambliss HO, Church TS, Trivedi MH Depression and anxiety 2016 May -
COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
Shukla AA, Jha M, Birchfield T, Mukherjee S, Gleason K, Abdisalaam S, Asaithamby A, Adams-Huet B, Tamminga CA, Ghose S Schizophrenia research 2016 Mar -
Attitudes Towards Substance Use Disorders and Association with Motivational Interviewing Education: A Survey of Psychiatry Chief Residents.
Jha MK, Abele MK, Brown JA, Ibrahim H, Wakhlu S Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2016 Mar -
Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.
Jha MK, Minhajuddin A, Greer TL, Carmody T, Rush AJ, Trivedi MH PloS one 2016 11 12 e0167901 -
Commentary: Clinical Approach to the Differential Diagnosis between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders.
Jha MK, Ivleva E Frontiers in psychiatry 2016 7 23 -
Altered GABA neurotransmission in major depressive disorder: Re-analyzing publicly available data.
Jha MK, Sachdeva S European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2016 Jan -
A Case of Frontotemporal Dementia Presenting With Treatment-Refractory Psychosis and Extreme Violence: Response to Combination of Clozapine, Medroxyprogesterone, and Sertraline.
Jha MK, Lambert ES, Beadles BA, Spradling B, Martinez R, Renfro N, Byerly M Journal of clinical psychopharmacology 2015 Oct -
Training psychiatry residents at correctional facilities.
Jha MK, Fuehrlein BS, North CS, Brenner AM Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2015 Feb 39 1 123-4 -
Teaching Motivational Interviewing Skills to Psychiatry Trainees: Findings of a National Survey.
Abele M, Brown J, Ibrahim H, Jha MK Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2014 May -
Availability and attitudes toward correctional psychiatry training: results of a national survey of training directors.
Fuehrlein BS, Jha MK, Brenner AM, North CS The journal of behavioral health services & research 2014 Apr 41 2 244-50 -
Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.
Jha MK, Minhajuddin A, Thase ME, Jarrett RB Journal of affective disorders 2014 167 37-43 -
Can we address the shortage of psychiatrists in the correctional setting with exposure during residency training?
Fuehrlein BS, Jha MK, Brenner AM, North CS Community mental health journal 2012 Dec 48 6 756-60 -
Post adoption depression.
Fields ES, Meuchel JM, Jaffe CJ, Jha M, Payne JL Archives of women's mental health 2010 Apr 13 2 147-51
-
Clinical and sociodemographic features of the Texas resilience against depression (T-RAD) study: Findings from the initial cohort.
New Patient Appointment Accepting Virtual Visits or 214-645-8500 or 214-645-2225